Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma

Miller, 2018, Cancer statistics for Hispanics/Latinos, 2018, CA Cancer J Clin, 68, 425, 10.3322/caac.21494 Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107 Zhu, 2018, Medium or large hepatocellular carcinoma: sorafenib combined with transarterial chemoembolization and radiofrequency ablation, Radiology, 288, 300, 10.1148/radiol.2018172028 Yang, 2016, Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment, World J Gastroenterol, 22, 2993, 10.3748/wjg.v22.i10.2993 Vogel, 2018, Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 29, iv238, 10.1093/annonc/mdy308 Kim, 2015, Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma, J Hepatol, 62, 1304, 10.1016/j.jhep.2015.01.022 Hiraoka, 2017, Hepatic function during repeated TACE procedures and prognosis after introducing sorafenib in patients with unresectable hepatocellular carcinoma: multicenter analysis, Dig Dis, 35, 602, 10.1159/000480256 Lin, 2018, Label-free classification of hepatocellular-carcinoma grading using second harmonic generation microscopy, Biomed Opt Express, 9, 3783, 10.1364/BOE.9.003783 Purcell, 2020, Influence of pretreatment tumor growth rate on objective response of hepatocellular carcinoma treated with transarterial chemoembolization, J Gastroenterol Hepatol, 35, 305, 10.1111/jgh.14816 Bi, 2019, Artificial intelligence in cancer imaging: clinical challenges and applications, CA Cancer J Clin, 69, 127, 10.3322/caac.21552 Ji, 2019, Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes, Radiology, 290, 90, 10.1148/radiol.2018181408 Llovet, 2002, Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial, Lancet, 359, 1734, 10.1016/S0140-6736(02)08649-X Kim, 2018, Predicting survival using pretreatment CT for patients with hepatocellular carcinoma treated with transarterial chemoembolization: comparison of models using radiomics, AJR Am J Roentgenol, 211, 1026, 10.2214/AJR.18.19507 Hao, 2021, Prognostic value of tumoral and peritumoral magnetic resonance parameters in osteosarcoma patients for monitoring chemotherapy response, Eur Radiol, 31, 3518, 10.1007/s00330-020-07338-y Wu, 2022, Can peritumoral radiomics improve the prediction of malignancy of solid pulmonary nodule smaller than 2 cm?, Acad Radiol, 29, S47, 10.1016/j.acra.2020.10.029 Ma, 2021, A CT-based tumoral and mini-peritumoral radiomics approach: differentiate fat-poor angiomyolipoma from clear cell renal cell carcinoma, Cancer Manag Res, 13, 1417, 10.2147/CMAR.S297094 Chen, 2021, Clinical-radiomic analysis for pretreatment prediction of objective response to first transarterial chemoembolization in hepatocellular carcinoma, Liver Cancer, 10, 38, 10.1159/000512028 Kong, 2021, Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE, Eur Radiol, 31, 7500, 10.1007/s00330-021-07910-0 Kuang, 2010, Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells, Hepatology, 51, 154, 10.1002/hep.23291 Budhu, 2006, Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment, Cancer Cell, 10, 99, 10.1016/j.ccr.2006.06.016 Lee, 2013, Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization, BMC Cancer, 13, 5, 10.1186/1471-2407-13-5 Tian, 2019, Alpha-fetoprotein assessment for hepatocellular carcinoma after transarterial chemoembolization, Abdom Radiol (NY), 44, 3304, 10.1007/s00261-019-02116-x Wang, 2020, Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?, Eur Radiol, 30, 5337, 10.1007/s00330-020-06861-2 Granito, 2021, TRANS-TACE: prognostic role of the transient hypertransaminasemia after conventional chemoembolization for hepatocellular carcinoma, J Pers Med, 11, 1041, 10.3390/jpm11101041 Sun, 2018, A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study, Lancet Oncol, 19, 1180, 10.1016/S1470-2045(18)30413-3